Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.12.011Source: DataRank Database

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: greenTopics (50)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Andrew C. Harris ORCID,Lev Gorfinkel ORCID,Katarzyna Ibanez ORCID,Eric R. Tkaczyk ORCID,Sandra A. Mitchell ORCID

Live enrichment

PubMed:39701289 PMC:PMC11816905 OpenAlex:https://openalex.org/W4405493927

National Institutes of Health

Grant: 1R13HL172559-01

Research and Education towards Solutions for Late effects to Innovate, Excel, and Nurture after chronic Graft-versus-Host Disease (RESILIENT after cGVHD)

NHLBI NIH HHS

Grant: R13 HL172559

CSRD VA

Grant: I01 CX002721

NCI NIH HHS

Grant: P30 CA008748

NHLBI NIH HHS

Grant: R01 HL169944

CSRD VA

Grant: IK2 CX001785

Pediatric Transplantation and Cellular Therapy Consortium

FWCI

0.00

Citation Percentile

0.3%

greenLicense: CC BY NC ND

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11816905/

publisherhttps://api.elsevier.com/content/article/PII:S2666636724008121?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636724008121?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtct.2024.12.011

Fields of Study

Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchT-cell and B-cell Immunology03 medical and health sciences0302 clinical medicineHumansGraft vs Host DiseaseChildChronic DiseaseAdolescentChild, PreschoolCell- and Tissue-Based TherapySurvivorship

MeSH Terms

SurvivorshipAdolescentChildChild, PreschoolChronic DiseaseGraft vs Host DiseaseHumansHematopoietic Stem Cell TransplantationCell- and Tissue-Based Therapy

Keywords

MedicineHematopoietic cellDiscontinuationHematopoietic stem cell transplantationDiseaseTransplantationGraft-versus-host diseaseSurvivorship curveIntensive care medicineChronic diseaseImmunologyHaematopoiesisStem cellInternal medicineCancerBiologyNatural historyChronic GvhdTherapy DiscontinuationPhasesAdolescentChild, PreschoolCell- and Tissue-Based TherapyHumansGraft vs Host DiseaseSurvivorshipChildArticle